Daewoong Pharmaceutical's affiliate, M Circle, showcased a fully automated administrative process for managing chronic diseases in primary care, significantly reducing operational burdens. Over 5,600 healthcare professionals participated in the online seminar, demonstrating high interest in practical applications.
On June 24, M Circle announced that it shared a case study on chronic disease management in primary care, presented by Lee Dae-geun, director of Seoul Jeongtong Union Clinic, during an online seminar hosted on the medical platform Dr. Bill. The seminar aimed to introduce patient management cases utilizing the digital healthcare platform Welcheck in primary care settings.
During the seminar, Lee discussed his experiences and outcomes from implementing the "Welcheck-based chronic disease management program in primary care." Seoul Jeongtong Union Clinic has established personalized care plans for patients and continuously monitors blood pressure and blood sugar data. This approach has enhanced continuity in patient management while alleviating administrative burdens.
The chronic disease management program in primary care, operated by the Ministry of Health and Welfare and the Health Insurance Review and Assessment Service, assigns local clinics as primary care providers responsible for developing annual management plans for patients with hypertension and diabetes, offering education, counseling, and monitoring. Currently, primary care institutions nationwide can participate.
Welcheck is a platform that integrates and manages patient health data, enabling healthcare professionals to utilize this information in their practice. It enhances patient engagement through features like record-based monitoring and educational materials. The entire process, from sending patient invitations to automated consent forms, collecting questionnaires, developing care plans, and evaluations, has been digitized. It also supports the automatic compilation and submission of materials required by the Health Insurance Review and Assessment Service.
Lee stated, "The use of Welcheck has significantly reduced administrative burdens, and both patient and healthcare provider satisfaction have increased due to continuous monitoring of health data."
The seminar also highlighted the benefits for patients participating in the chronic disease management program. Participants can receive reduced out-of-pocket expenses and up to 80,000 won annually through the health promotion support program.
The operational benefits for healthcare institutions were also presented. According to the presentation, utilizing the fee structure of the program could yield additional reimbursements of up to 380,000 won per patient. Operating the program with 500 patients could potentially generate over 10 million won in additional revenue monthly.
Lee expressed hope that more healthcare institutions would leverage digital healthcare platforms to enhance the quality of chronic disease management and provide patient-centered medical services.
Meanwhile, Daewoong Pharmaceutical plans to further advance its digital healthcare open innovation strategy. Last year, M Circle launched the "Welcheck-Egis Chart" integration service, which automatically links electronic medical record (EMR) systems.
* This article has been translated by AI.
Copyright ⓒ Aju Press All rights reserved.